dc.contributor.author | Mountzouris, KC | en |
dc.contributor.author | Tsirtsikos, P | en |
dc.contributor.author | Kalamara, E | en |
dc.contributor.author | Nitsch, S | en |
dc.contributor.author | Schatzmayr, G | en |
dc.contributor.author | Fegeros, K | en |
dc.date.accessioned | 2014-06-06T06:47:44Z | |
dc.date.available | 2014-06-06T06:47:44Z | |
dc.date.issued | 2007 | en |
dc.identifier.issn | 00325791 | en |
dc.identifier.uri | http://62.217.125.90/xmlui/handle/123456789/3781 | |
dc.relation.uri | http://www.scopus.com/inward/record.url?eid=2-s2.0-33947519135&partnerID=40&md5=9337c526c5eecc7bff41c1ba69de9012 | en |
dc.subject | Broiler | en |
dc.subject | Cecal microflora | en |
dc.subject | Chicken | en |
dc.subject | Microbial enzyme | en |
dc.subject | Probiotic | en |
dc.subject.other | Bacteria (microorganisms) | en |
dc.subject.other | Bifidobacterium | en |
dc.subject.other | Enterococcus | en |
dc.subject.other | Glycine max | en |
dc.subject.other | Lactobacillus | en |
dc.subject.other | Pediococcus | en |
dc.subject.other | Posibacteria | en |
dc.subject.other | Zea mays | en |
dc.subject.other | probiotic agent | en |
dc.subject.other | volatile fatty acid | en |
dc.subject.other | aging | en |
dc.subject.other | animal | en |
dc.subject.other | animal disease | en |
dc.subject.other | animal food | en |
dc.subject.other | article | en |
dc.subject.other | Bifidobacterium | en |
dc.subject.other | cecum | en |
dc.subject.other | chicken | en |
dc.subject.other | clinical trial | en |
dc.subject.other | controlled clinical trial | en |
dc.subject.other | controlled study | en |
dc.subject.other | diet | en |
dc.subject.other | drug effect | en |
dc.subject.other | Enterococcus | en |
dc.subject.other | glycolysis | en |
dc.subject.other | growth, development and aging | en |
dc.subject.other | Lactobacillus | en |
dc.subject.other | male | en |
dc.subject.other | metabolism | en |
dc.subject.other | microbiology | en |
dc.subject.other | Pediococcus | en |
dc.subject.other | randomized controlled trial | en |
dc.subject.other | weight gain | en |
dc.subject.other | Aging | en |
dc.subject.other | Animal Feed | en |
dc.subject.other | Animal Nutrition Physiology | en |
dc.subject.other | Animals | en |
dc.subject.other | Bifidobacterium | en |
dc.subject.other | Cecum | en |
dc.subject.other | Chickens | en |
dc.subject.other | Diet | en |
dc.subject.other | Enterococcus | en |
dc.subject.other | Fatty Acids, Volatile | en |
dc.subject.other | Glycolysis | en |
dc.subject.other | Lactobacillus | en |
dc.subject.other | Male | en |
dc.subject.other | Pediococcus | en |
dc.subject.other | Probiotics | en |
dc.subject.other | Weight Gain | en |
dc.title | Evaluation of the efficacy of a probiotic containing Lactobacillus, Bifidobacterium, Enterococcus, and Pediococcus strains in promoting broiler performance and modulating cecal microflora composition and metabolic activities | en |
heal.type | journalArticle | en |
heal.publicationDate | 2007 | en |
heal.abstract | The aim of this work was to investigate the efficacy of a new multibacterial species probiotic in broiler nutrition. The probiotic contained 2 Lactobacillus strains, 1 Bifidobacterium strain, 1 Enterococcus strain, and 1 Pediococcus strain. Four hundred 1-d-old male Cobb broilers were allocated in 4 experimental treatments for 6 wk. The experimental treatments received a corn-soybean basal diet and were as follows: ""control,"" with no other additions; ""probiotic in feed and water,"" (PFW) with probiotic administered at 1 g/kg of feed for the whole period and in water on scheduled intervals during the first 4 wk; ""probiotic in feed,"" (PF) with probiotic in feed as in PFW; and ""antibiotic,"" (AB) with addition of avilamycin at 2.5 mg/kg of feed. Salinomycin Na was used as a coccidiostat. Each treatment had 5 replicates of 20 broilers. Treatment effects on parameters of broiler performance and cecal microbial ecology were determined. Broiler BW, feed intake, and feed conversion ratio were determined on a weekly and overall basis. Cecal microflora composition, concentration of volatile fatty acids, and activities of 5 bacterial glycolytic enzymes (α-galactosidase, β-galactosidase, α-glucosidase, β-glucosidase, and β-glucuronidase) were determined at the end of the experiment. Overall, treatment PFW displayed a growth-promoting effect that did not differ from AB. Overall, feed conversion ratio in treatment AB was significantly better (P ≤ 0.01) than the control treatment, whereas treatments PFW and PF were intermediate and not different from AB. Concentrations of bacteria belonging to Bifidobacterium spp., Lactobacillus spp., and gram-positive cocci were significantly (P ≤ 0.05) higher in treatments PFW and PF compared with the control and AB treatments. Treatments PFW and PF had significantly higher specific activities of α-galactosidase and β-galactosidase compared with the control and AB treatments. In conclusion, probiotic treatment PFW displayed a growth-promoting effect that was comparable to avilamycin treatment. In addition, treatments PFW and PF modulated the composition and, to an extent, the activities of the cecal microflora, resulting in a significant probiotic effect. ©2007 Poultry Science Association Inc. | en |
heal.journalName | Poultry Science | en |
dc.identifier.issue | 2 | en |
dc.identifier.volume | 86 | en |
dc.identifier.spage | 309 | en |
dc.identifier.epage | 317 | en |
Αρχεία | Μέγεθος | Μορφότυπο | Προβολή |
---|---|---|---|
Δεν υπάρχουν αρχεία που σχετίζονται με αυτό το τεκμήριο. |